Activity Overview
This educational activity is an archive of the live presentation held on June 22, 2026.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward a global audience of oncology clinicians, including medical oncologists, thoracic oncologists, pulmonologists, advanced practice providers, oncology nurses, pharmacists, and other members of the multidisciplinary cancer care team involved in the management of patients with NSCLC.
Learning Objective
Upon successful completion of this activity, you should be better prepared to:
- Implement
multidisciplinary strategies to monitor, mitigate, and manage high-impact
toxicities associated with TROP2-targeted ADCs.
Solange Peters, MD, PhD
Full Professor
Chair of Medical Oncology and Oncology Program
University Hospital of Lausanne
Lausanne, Switzerland
Stephanie McDonald, FNP-BC, AOCNP
Nurse Practitioner
Department of Thoracic Oncology
Dana-Farber Cancer Institute
Boston, MA
Antonio Passaro, MD, PhD
Medical Director With High Specialization Responsibility
Division of Thoracic Oncology
European Institute of Oncology IRCCS
Milan, Italy
Jacob Sands, MD
Associate Chief, Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Assistant Professor
Harvard Medical School
Boston, MA
Full faculty information and disclosures are available by reviewing the program workbook, linked here.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.